AKER

Akers Biosciences (AKER)

Akers Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKER

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/10/16	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/10/16	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/10/05	23 : 00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/09/23	01 : 53	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/09/14	06 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/09/04	05 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/07/03	06 : 00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/07/03	05 : 01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AKER	Akers Biosciences Inc
2021/05/18	19 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AKER	Akers Biosciences Inc
2021/05/18	19 : 07	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:AKER	Akers Biosciences Inc
2021/05/12	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AKER	Akers Biosciences Inc
2021/05/12	05 : 28	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/30	05 : 10	GlobeNewswire Inc.	Contango Announces the Appointment of Two New Directors	NASDAQ:AKER	Akers Biosciences Inc
2021/04/29	06 : 26	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/27	19 : 02	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/22	19 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/22	06 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/22	05 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/22	05 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/22	05 : 49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AKER	Akers Biosciences Inc
2021/04/17	01 : 30	Business Wire	Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger	NASDAQ:AKER	Akers Biosciences Inc
2021/04/13	22 : 00	Business Wire	Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial	NASDAQ:AKER	Akers Biosciences Inc
2021/04/12	22 : 00	Business Wire	Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board	NASDAQ:AKER	Akers Biosciences Inc
2021/03/26	08 : 37	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:AKER	Akers Biosciences Inc
2021/03/24	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AKER	Akers Biosciences Inc
2021/03/24	02 : 44	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AKER	Akers Biosciences Inc
2021/03/23	06 : 22	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:AKER	Akers Biosciences Inc
2021/03/22	21 : 00	Business Wire	Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals	NASDAQ:AKER	Akers Biosciences Inc
2021/03/20	06 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2021/03/20	03 : 03	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:AKER	Akers Biosciences Inc